Trials & Tribulations Continuous temperature tracking helps manage infection risk after CAR T-cell therapy May 05, 2023Vol.49 No.18By Ruth Phillips
In Brief Leslie A. Crews appointed co-leader of the Hematologic Malignancies Research Program at Moores April 28, 2023Vol.49 No.17
Drugs & Targets Prelude Therapeutics to collaborate with BeiGene to evaluate PRT2527 + zanubrutinib in hematologic cancers March 17, 2023Vol.49 No.11
In Brief Jordan Berlin named director of Division of Hematology and Oncology at Vanderbilt February 10, 2023Vol.49 No.06
In Brief Douglas Gladstone named chief of hematologic malignancies at Northwell Health January 13, 2023Vol.49 No.02
In Brief Neil Palmisiano appointed deputy director of phase I therapeutics for hematologic malignancies at Rutgers October 07, 2022Vol.48 No.36
Drugs & TargetsFree Poseida, Roche to collaborate on allogeneic CAR T-cell therapies for hematologic malignancies August 05, 2022Vol.48 No.31
